Stockscreener 앱 받기
39.53
0.93%
-0.37
시간 외 거래:
39.53
전일 마감가:
$39.90
열려 있는:
$40.04
하루 거래량:
4.75M
Relative Volume:
1.11
시가총액:
$16.89B
수익:
$2.31B
순이익/손실:
$1.66B
주가수익비율:
17.21
EPS:
2.297
순현금흐름:
$827.02M
1주 성능:
-0.03%
1개월 성능:
+5.30%
6개월 성능:
+18.85%
1년 성능:
+49.56%
1일 변동 폭
$39.49
$40.21
1주일 범위
$39.23
$40.50
52주 변동 폭
$24.05
$41.24
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
39.53 | 17.05B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.15 | 107.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
742.00 | 78.84B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.93 | 60.05B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
915.36 | 55.10B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.60 | 45.09B | 447.02M | -1.18B | -906.14M | -6.1812 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 개시 | Goldman | Buy |
| 2025-05-16 | 개시 | Morgan Stanley | Overweight |
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
How Royalty Pharma plc (RPD) stock correlates with oil marketsWeekly Market Outlook & Weekly High Return Stock Opportunities - Newser
Royalty Pharma PLC $RPRX Shares Purchased by River Road Asset Management LLC - MarketBeat
Why Royalty Pharma plc (RPD) stock could break out in 2025July 2025 Spike Watch & Precise Swing Trade Entry Alerts - Newser
Will Royalty Pharma plc (RPD) stock maintain strong growthQuarterly Earnings Report & Risk Managed Investment Strategies - Newser
Technical Reactions to RPRX Trends in Macro Strategies - news.stocktradersdaily.com
Royalty Pharma PLC $RPRX Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by Elo Mutual Pension Insurance Co - MarketBeat
Patient Capital Management LLC Buys 15,342 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Northwest & Ethical Investments L.P. Takes $1.67 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
Russell Investments Group Ltd. Sells 286,493 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Franklin Resources Inc. Buys 151,248 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma Insider Sold Shares Worth $2,682,505, According to a Recent SEC Filing - MarketScreener
Creative Planning Buys 9,718 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma’s Q3 2025 Earnings Call Highlights - MSN
Terrance Coyne Sells 69,582 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
Is Royalty Pharma PLC Gaining or Losing Market Support? - Benzinga
Rhenman & Partners Asset Management AB Lowers Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma EVP Coyne sells $2.68 million in shares By Investing.com - Investing.com South Africa
Royalty Pharma EVP Coyne sells $2.68 million in shares - Investing.com
RPRX CFO Terrance P. Coyne reports 10b5-1 share sales - Stock Titan
Swiss National Bank Purchases 50,100 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma to Present at Upcoming Investor Conferences - Enidnews.com
Legal & General Group Plc Has $97.97 Million Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Vestor Capital LLC Sells 399,100 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc : Technically solid - MarketScreener
Handelsbanken Fonder AB Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Horizon Kinetics Asset Management LLC Boosts Stake in Royalty Pharma PLC $RPRX - MarketBeat
Mediolanum International Funds Ltd Has $2.01 Million Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
DNB Asset Management AS Increases Position in Royalty Pharma PLC $RPRX - MarketBeat
Shareholder TPC RP 2021 LLC Files To Sell 65,832 Of Royalty Pharma PLC [RPRX] - TradingView
Vanguard Group Inc. Trims Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Sierra Summit Advisors LLC Buys Shares of 19,360 Royalty Pharma PLC $RPRX - MarketBeat
CenterBook Partners LP Increases Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Ensign Peak Advisors Inc Raises Stake in Royalty Pharma PLC $RPRX - MarketBeat
Prudential PLC Has $4.68 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
55,337 Shares in Royalty Pharma PLC $RPRX Bought by Entropy Technologies LP - MarketBeat
Royalty Pharma (NASDAQ:RPRX) EVP George Lloyd Sells 132,426 Shares - MarketBeat
Royalty Pharma PLC (GB00BMVP7Y09.SG) stock price, news, quote and history - Yahoo Finance Australia
Royalty Pharma PLC $RPRX Shares Sold by Brandywine Global Investment Management LLC - MarketBeat
ABN AMRO Bank N.V. Buys New Shares in Royalty Pharma PLC $RPRX - MarketBeat
Can WPIL Limited Deliver Through Market Peaks and TroughsVolume Profile Analysis & Start Investing With Free Smart Watchlists - earlytimes.in
Royalty Pharma Insider Sold Shares Worth $5,192,656, According to a Recent SEC Filing - MarketScreener
[Form 4] Royalty Pharma plc Insider Trading Activity - Stock Titan
Empowered Funds LLC Cuts Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Terrance Coyne Sells 69,594 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
TD Cowen Downgrades Royalty Pharma (NASDAQ:RPRX) to Hold - MarketBeat
How Royalty Pharma plc (RPD) stock compares with top peersGold Moves & Short-Term Swing Trade Alerts - newser.com
SG Americas Securities LLC Acquires 15,218 Shares of Royalty Pharma PLC $RPRX - MarketBeat
7,082 Shares in Royalty Pharma PLC $RPRX Bought by Savant Capital LLC - MarketBeat
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.02%
자본화:
|
볼륨(24시간):